St. Jude Medical wins CE Mark for Infinity DBS device

St. Jude Medical (NYSE:STJ) said today that it won CE Mark approval in the European Union for its Infinity deep-brain stimulation device and directional lead for treating movement disorders. Little Canada, Minn.-based St. Jude said the Infinity system is designed so that Apple (NSDQ:AAPL) mobile devices can be used as wireless controllers, via a Bluetooth connection. It’s the only upgradable DBS system for movement disorders including Parkinson’s disease, tremor and dystonia. The directional leads are designed to allow doctors to “steer” current to different parts of the brain, tailoring treatment to reduce side effects, St. Jude said. “The Infinity DBS system, including our directional lead and wireless technology, represents a major step forward in our DBS product portfolio, demonstrating St. Jude Medical’s commitment to patient-centric solutions to help alleviate the debilitating effects of movement disorders,” president Dr. Eric Fain said in prepared remarks. “Not only are we able to offer therapy solutions for a broad set of indications for movement disorders, but we’ve also designed the system to provide patients the best possible experience with their therapy while helping physicians manage their patients more efficiently and effectively.” Patients using the Infinity system can link it to Apple’s iPod Touch; physicians can program the device using the Apple iPad Mini, according to St. Jude. “Th...
Source: Mass Device - Category: Medical Equipment Authors: Tags: Neuromodulation/Neurostimulation Regulatory/Compliance CE Mark Deep-brain stimulation St. Jude Medical Source Type: news